8-K 1 d8k.htm FORM 8-K Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) October 17, 2005

 


 

 

DEL LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 


 

DELAWARE   1-5439   13-1953103
(State of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)

178 EAB Plaza

Uniondale, NY

      11556
(Address of principal executive offices)       (Zip Code)
(516) 844-2020        
(Registrant’s telephone number)        

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



Item 7.01. Regulation FD Disclosure

 

Pursuant to Regulation FD, the registrant furnishes the information set forth below.

 

Workforce Reduction

 

As part of our efforts to streamline our organization and reduce costs, we completed a workforce reduction program in September 2005. This program entailed an assessment of our workforce requirements across all of our major departments and resulted in the elimination of 55 positions at various levels. For the twelve months ended June 30, 2005, salaries and benefits paid to these terminated employees were approximately $6.7 million, and we expect to realize similar cost savings going forward. In connection with the workforce reduction program, we expect to record a one-time severance charge of approximately $2.0 million in the three months ended September 30, 2005.

 

Operational Initiatives

 

In addition to our focus on realizing cost savings, we are committed to improving the efficiency of our operations. Synergetics Installations Worlwide, Inc., or Synergetics, has completed an assessment of our operations, and we have jointly developed a plan to implement a number of sales and operational process improvements that we believe will reduce inefficiencies and improve customer service as well as assist us in realizing previously identified cost savings. Specifically, we are in the process of implementing sales and operational process initiatives designed to improve:

 

    our sales forecasting, demand planning and production scheduling, which we expect will allow us to improve manufacturing productivity and reduce manufacturing costs;

 

    the efficiency level of our manufacturing facilities, which we expect will reduce manufacturing costs while lowering overall inventory requirements; and

 

    the process of identifying, evaluating and selling promotional products, which we expect will allow us to improve margins on promotional products, reduce promotional returns and lower promotional inventory requirements.

 

We currently anticipate implementing these and other initiatives by the end of 2006. Upon completion of these initiatives, we anticipate annualized cost savings of approximately $10.0 million. We estimate that we will incur one-time consulting fees and implementation costs associated with these anticipated cost savings of up to $3.0 million.

 

 

Refinancing Transactions

 

We intend to issue $185.0 million of debt securities in a private placement and enter into a new two-year $75.0 million asset-based revolving credit facility, or the interim revolver. We intend to use the proceeds from the sale of the new debt securities and borrowings under the interim revolver to repay all outstanding borrowings under our existing senior credit facilities (and terminate all commitments thereunder). We refer to the issuance of the new debt securities, the borrowings under the interim revolver and the application of the proceeds as the refinancing transactions. We have received a commitment from the agent under the interim revolver to replace the interim revolver with an $85.0 million asset-based revolving credit facility, or the ABL credit facility. We expect that the interim revolver will be in place until the initial field examinations and closing conditions required by the ABL credit facility are completed, which we expect to occur by December 31, 2005. Upon the closing of the ABL credit facility, all borrowings under the interim revolver will be repaid and the interim revolver will be terminated. The availability of the interim revolver will be subject to a borrowing base limitation.

 

2


Summary Historical and Pro Forma Consolidated Financial Data

 

The summary historical consolidated financial data presented below for the fiscal years ended December 31, 2002, 2003 and 2004 have been derived from the audited consolidated financial statements of Del Laboratories, Inc. and its subsidiaries. The summary historical consolidated financial data for the six months ended June 30, 2004, the period January 1, 2005 to January 31, 2005, the period February 1, 2005 to June 30, 2005 and as of June 30, 2005 have been derived from the unaudited consolidated financial statements of Del Laboratories, Inc. and its subsidiaries, which have been prepared on a basis consistent with the audited consolidated financial statements as of and for the year ended December 31, 2004. In the opinion of management, such unaudited financial data reflect all material adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the results for those periods. The results of operations for the five months ended June 30, 2005 are not necessarily indicative of the operating results to be expected for the full year or any future period. The results of operations for the twelve months ended June 30, 2005 were derived from the foregoing audited and unaudited financial statements.

 

The summary unaudited pro forma consolidated statement of earnings data and other financial data for the twelve months ended June 30, 2005 give effect to the merger and the refinancing transactions as if they had occurred on January 1, 2004. The summary unaudited pro forma balance sheet data as of June 30, 2005 give effect to the refinancing transactions as if they occurred on such date. The summary unaudited pro forma consolidated financial data do not purport to represent what our results of operations or financial information would have been if the merger and the refinancing transactions had occurred as of the date indicated, or what such results will be for any future period.

 

The merger was completed on January 27, 2005. Since the actual results for the period January 28, 2005 to January 31, 2005 were not material to the Successor Period of the quarter or to the projected annual results, we have utilized January 31, 2005 as the acquisition date. As a result of the merger, our capital structure and our basis of accounting differ from those prior to the merger. Our financial data in respect of all reporting periods subsequent to January 31, 2005 reflect the merger under the purchase method of accounting. Therefore, our financial data for the period before the merger (which we refer to as the Predecessor Period) generally will not be comparable to our financial data for the period after the merger (which we refer to as the Successor Period). As a result of the merger, our consolidated statement of operations for the Successor Period includes interest expense and amortization expense related to debt issuance costs related to acquisition indebtedness and management fees that did not exist prior to the acquisition. Further, as a result of purchase accounting, the fair values of our inventories, intangible assets, and fixed assets on the date of the merger became their new “cost” basis. Accordingly, the cost of inventories, the amortization of intangible assets with finite lives and the depreciation of fixed assets in the Successor Period are based upon their newly established cost basis. Additionally, the fair value of our pension assets and liabilities were adjusted as a result of purchase accounting; therefore, pension expense for the Successor Period is based upon the newly established fair values. Other effects of purchase accounting in the Successor Period are not considered significant.

 

3


    Predecessor

    Successor

   

Twelve
Months
Ended
June 30,

2005


       
    Year Ended December 31,

    Six Months
Ended
June 30,
2004


    Jan. 1, 2005
– Jan. 31,
2005


    Feb. 1, 2005
– June 30,
2005


      Pro Forma
Twelve
Months Ended
June 30, 2005


 
    2002

    2003

    2004

           
                      (unaudited)     (unaudited)     (unaudited)     (unaudited)     (unaudited)  
    (dollars in thousands)  

Statement of Earnings Data:

                                                               

Net sales

  $ 350,668     $ 385,953     $ 396,675     $ 186,013     $ 18,206     $ 179,821     $ 408,689     $ 408,689  

Cost of goods sold

    171,346       185,772       198,425       93,585       9,718       103,225       217,783       212,028  
   


 


 


 


 


 


 


 


Gross profit

    179,322       200,181       198,250       92,428       8,488       76,596       190,906       196,661  

Selling and administrative expenses

    145,983       161,644       166,732       82,729       11,475       73,163       168,641       168,984  

Severance expenses

    45       2,033       20       3                   17       17  

Merger expenses

                1,415       216       18,974       4,651       24,824       1,199  
   


 


 


 


 


 


 


 


Income (loss) from operations

    33,294       36,504       30,083       9,480       (21,961 )     (1,218 )     (2,576 )     26,461  

Other income (expense), net

                                                               

Interest expense, net

    (4,663 )     (4,185 )     (3,584 )     (1,859 )     (264 )     (11,732 )     (13,721 )     (35,725 )

Gain (loss) on sale of facility and land

    2,428             (146 )     (41 )                 (105 )     (105 )

Other, net

    (144 )     579       331       (354 )     (232 )     77       530       530  
   


 


 


 


 


 


 


 


Other expense, net

    (2,379 )     (3,606 )     (3,399 )     (2,254 )     (496 )     (11,655 )     (13,296 )     (35,300 )
   


 


 


 


 


 


 


 


Earnings before income taxes

    30,915       32,898       26,684       7,226       (22,457 )     (12,873 )     (15,872 )     (8,839 )

Income tax expense (benefit)

    11,412       12,524       11,075       2,789       (24,434 )     463       (15,685 )     (3,491 )
   


 


 


 


 


 


 


 


Net income (loss)

  $ 19,503     $ 20,374     $ 15,609     $ 4,437     $ 1,977     $ (13,336 )   $ (187 )   $ (5,348 )
   


 


 


 


 


 


 


 


Other Financial Data:

                                                               

EBITDA (1)

  $ 46,630     $ 51,617     $ 47,740     $ 17,555     $ (20,681 )   $ 7,918     $ 17,422     $ 48,631  

Adjusted EBITDA (1)

    45,210       53,571       49,784       18,478       (1,374 )     18,566       48,498       59,534  

Depreciation and amortization

    11,052       14,534       17,472       8,470       1,512       9,059       19,573       21,745  

Capital expenditures

    9,078       18,200       9,525       5,387       797       2,929       7,864       7,864  

Cash interest expense

    4,467       3,970       3,674       1,766       140       4,212       6,260       33,062  

Ratio of total net senior secured debt to Adjusted EBITDA

 

    3.5 x

Ratio of total net debt to Adjusted EBITDA

 

    6.4 x

Ratio of Adjusted EBITDA to cash interest expense

 

    1.8 x

 

     As of June 30, 2005

     Actual

   Pro Forma

     (unaudited)    (unaudited)
     (in thousands)
Balance Sheet Data:     

Cash and cash equivalents

   $ 6,229    $ 5,011

Working capital (excluding cash and debt) (2)

     170,475      171,693

Total assets

     733,829      732,542

Total secured debt

     205,483      211,983

Total debt (including current portion of long-term debt)

     379,383      385,883

Total net debt

     373,154      380,872

Shareholders’ equity

     129,502      122,933

(1) EBITDA is defined as net income (loss), plus interest expense net of interest income, income tax provision (benefit), depreciation, and amortization, as set out in detail below. See footnote (a) below for a description of the adjustments included in pro forma EBITDA for the twelve months ended June 30, 2005. Adjusted EBITDA consists of EBITDA as adjusted to exclude certain items and expenses in accordance with the calculation of “Consolidated EBITDA,” as that term is defined under our credit agreement. Pro forma Adjusted EBITDA presents Adjusted EBITDA on a pro forma basis and as further adjusted for the cost savings specified below.

 

4


We believe that the inclusion of supplementary adjustments to EBITDA applied in presenting Adjusted EBITDA are appropriate to provide additional information to investors about our historical performance and certain initiatives that we have implemented since the merger. EBITDA and Adjusted EBITDA are not recognized terms under GAAP and do not purport to be alternatives to net income as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Additionally, EBITDA and Adjusted EBITDA are not intended to be measures of free cash flow for management’s discretionary use, as they do not reflect certain cash requirements such as interest payments, tax payments and debt service requirements. Because not all companies use identical calculations, these presentations of EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures of other companies.

 

EBITDA and Adjusted EBITDA are reconciled to net income (loss) as follows (unaudited):

 

    Predecessor

    Successor

   

Twelve
Months
Ended
June 30,
2005


   

Pro Forma
Twelve
Months Ended
June 30, 2005


 
    Year Ended December 31,

 

Six Months
Ended
June 30,

2004


 

Jan. 1, 2005
– Jan. 31,
2005


   

Feb. 1, 2005
– June 30,
2005


     
    2002

    2003

  2004

         
    (in thousands)  

Net income (loss)

  $ 19,503     $ 20,374   $ 15,609   $ 4,437   $ 1,977     $ (13,336 )   $ (187 )   $ (5,348 )

Income tax provision (benefit)

    11,412       12,524     11,075     2,789     (24,434 )     463       (15,685 )     (3,491 )

Interest expense, net

    4,663       4,185     3,584     1,859     264       11,732       13,721       35,725  

Depreciation and amortization

    11,052       14,534     17,472     8,470     1,512       9,059       19,573       21,745  
   


 

 

 

 


 


 


 


EBITDA (a)

    46,630       51,617     47,740     17,555     (20,681 )     7,918       17,422       48,631  

Non-cash charges, net (b)

    563       665     463     663     323       5,497       5,620       (547 )

Non-recurring (income) expenses (c)

    (1,983 )     1,289     1,581     260     18,974       4,651       24,946       1,321  

Sponsor monitoring fee

                      10       500       510       1,200  

Cost savings (d)

                                        8,929  
   


 

 

 

 


 


 


 


Adjusted EBITDA

  $ 45,210     $ 53,571   $ 49,784   $ 18,478   $ (1,374 )   $ 18,566     $ 48,498     $ 59,534  
   


 

 

 

 


 


 


 



(a) Pro forma EBITDA, for the twelve months ended June 30, 2005, reflects the following adjustments (in thousands): (i) an increase in selling and administrative expense of $690 for a total of $1,200 for the annual monitoring fee that we will pay to Kelso, (ii) a decrease in selling and administrative expenses of $2,107 for costs eliminated on consummation of the merger (including a decrease in salary and related benefits as a result of the retirement of our former CEO, the discontinuance of our employee stock ownership plan and other public company costs no longer incurred), (iii) a decrease in selling and administrative expense of $588 related to the elimination of the amortization of unrecognized prior service costs and transition obligations related to our pension plans, (iv) a decrease in selling and administrative expense of $23,625 related to the elimination of merger expenses recorded in the period from January 1, 2005 to June 30, 2005 and (v) a decrease in cost of sales of $5,579 recorded in the period from February 1, 2005 to June 30, 2005 related to the elimination of manufacturing profit added to inventory in purchase accounting.

 

5


(b) Non-cash charges, net consist of:

 

    Predecessor

  Successor

          Pro Forma
Twelve
Months
Ended
June 30,
 
    Year Ended
December 31,


    Six
Months
Ended
June 30,
2004


 

Jan. 1, 2005

– Jan. 31,

  Feb. 1, 2005
– June 30,
    Twelve
Months
Ended
June 30,
   
    2002

    2003

    2004

      2005

  2005

    2005

    2005

 
    (in thousands)  

Amortization of prior service cost and unrecognized net gain (loss) on pension plans

  $ 563     $    975     $    967     $    484   $ 102   $ 3     $ 588     $  

Foreign currency exchange (gain) loss

          (310 )     (504 )     179     221     (85 )     (547 )     (547 )

Inventory step-up recorded in purchase accounting

                              5,579       5,579        
   


 


 


 

 

 


 


 


Total

  $ 563     $ 665     $ 463     $ 663   $ 323   $ 5,497     $ 5,620     $ (547 )
   


 


 


 

 

 


 


 


(c)    Non-recurring (income) expenses consist of:

                                                           
    Predecessor

  Successor

          Pro Forma
Twelve
Months
Ended
June 30,
 
    Year Ended
December 31,


    Six
Months
Ended
June 30,
2004


 

Jan. 1, 2005

– Jan. 31,

  Feb. 1, 2005
– June 30,
    Twelve
Months
Ended
June 30,
   
    2002

    2003

    2004

      2005

  2005

    2005

    2005

 
    (in thousands)  

Merger expenses and change in control payments

  $     $     $ 1,415     $ 216   $ 18,974   $ 4,651     $ 24,824     $ 1,199  

(Gain) loss on sale of land and facility

    (2,428 )           146       41               105       105  

Severance

    45       2,033       20       3               17       17  

Provisions (recovery) of receivables from bankrupt customers

    400       (744 )                                
   


 


 


 

 

 


 


 


Total

  $  (1,983 )   $ 1,289     $ 1,581     $ 260   $  18,974   $    4,651     $  24,946     $ 1,321  
   


 


 


 

 

 


 


 


(d)    Pro forma cost savings consist of:

                                                           
                                          Pro Forma
Twelve
Months
Ended
June 30,
 
                                         
                                          2005

 
                                             

Staff and workforce reductions(i)

 

  $   6,740  

Closure of Elm warehouse(ii)

 

    293  

Reduction in marketing expenses(iii)

 

    1,400  

Additional savings from ex-CEO departmental expenses and public company expenses(iv)

 

    496  
     


Total

 

  $ 8,929  
     


  (i) Represents salaries and benefits for the twelve months ended June 30, 2005 for employees and long-term consultants terminated in connection with a workforce reduction program implemented in September 2005, which resulted in the elimination of 55 positions. In connection with this program, we expect to record a one-time severance charge of approximately $2.0 million in the three months ended September 30, 2005.
  (ii) Represents rent and occupancy expenses for the twelve months ended June 30, 2005 with a warehouse that was vacated in October 2005.
  (iii) Represents decreases in marketing and promotional expenses for certain pharmaceutical products.
  (iv) Represents administrative and other costs (including salaries) related to the office of the former Chairman and CEO for the twelve months ended June 30, 2005, who retired in connection with the merger, and other public company costs no longer incurred.

 

(2) Working capital is defined as current assets (excluding cash and cash equivalents) less current liabilities (excluding current portion of long-term debt and short-term debt).

 

6


Unaudited Pro Forma Consolidated Financial Information

 

The following unaudited pro forma financial information is based on the audited and unaudited consolidated financial statements of Del Laboratories, Inc. and its subsidiaries, as adjusted to illustrate the estimated pro forma effects of the merger (including the preliminary application of purchase accounting) and the refinancing transactions.

 

The unaudited pro forma consolidated balance sheet gives effect to the refinancing transactions as if they had occurred on June 30, 2005. The unaudited pro forma consolidated statements of operations give effect to the merger and the refinancing transactions as if they had occurred on January 1, 2004.

 

The unaudited pro forma adjustments are based upon available information and certain assumptions that we believe are reasonable.

 

The pro forma adjustments reflect our preliminary estimates of the purchase price allocation, which may change upon finalization of appraisals and other valuation studies. Any additional purchase price allocated to inventory for production profit would impact cost of goods sold subsequent to the date of the merger. Any additional purchase price allocated to property, plant and equipment or other finite-lived intangible assets would result in additional depreciation and amortization expense which may be significant.

 

The unaudited pro forma statements of operations data do not reflect certain one-time charges that we recorded or will record following the closing of the merger and the refinancing transactions. These one-time charges include (1) an approximately $5.6 million non-cash charge for the manufacturing profit added to inventory under purchase accounting, (2) a $6.6 million write-off of deferred financing fees associated with the repayment of our existing senior credit facilities and (3) a $23.6 million charge related to expenses incurred, including change in control payments, in connection with the merger.

 

The unaudited pro forma financial information is for informational purposes only and is not intended to represent or be indicative of the consolidated results of operations or financial position that we would have reported had the merger and the refinancing transactions been completed as of the date presented, and should not be taken as representative of our future consolidated results of operations or financial position.

 

7


UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET

AS OF JUNE 30, 2005

 

     Historical

   Adjustments

    Pro Forma

          (in thousands)      

Assets

                     

Cash and cash equivalents

   $ 6,229    $ (1,218 )(a)   $ 5,011

Accounts receivable, net

     90,621      —         90,621

Inventories

     114,946      —         114,946

Income taxes receivable

     12,184      —         12,184

Deferred income taxes

     26,818      —         26,818

Prepaid expenses and other current assets

     4,182      —         4,182
    

  


 

Total current assets

     254,980      (1,218 )     253,762

Property, plant and equipment, net

     50,022      —         50,022

Intangibles, net

     261,913      —         261,913

Goodwill

     132,763      —         132,763

Other assets

     28,262      (69 ) (b)     28,193

Deferred income taxes

     5,889      —         5,889
    

  


 

Total assets

   $ 733,829    $ (1,287 )   $ 732,542
    

  


 

Liabilities and Stockholders’ Equity

                     

Current portion of long-term debt

   $ 2,176    $ (2,000 )(a)   $ 176

Accounts payable

     47,909      —         47,909

Accrued liabilities

     30,367      (1,218 )     29,149
    

  


 

Total current liabilities

     80,452      (3,218 )     77,234

Interim revolver

     —        25,500  (a)     25,500

New debt securities

     —        185,000  (a)     185,000

Revolving credit facility

     5,000      (5,000 )(a)     —  

Term loan facility

     197,000      (197,000 )(a)     —  

Senior subordinated notes, net of unamortized discount

     173,900      —         173,900

Long-term pension liability, less current portion

     22,143      —         22,143

Deferred income taxes

     124,525      —         124,525

Other long-term debt, less current portion

     1,307      —         1,307
    

  


 

Total liabilities

     604,327      5,282       609,609

Shareholders’ equity

     129,502      (6,569 )(b)     122,933
    

  


 

Total liability and shareholders’ equity

   $ 733,829    $ (1,287 )   $ 732,542
    

  


 

 

See accompanying notes to unaudited pro forma consolidated balance sheet

 

8


NOTES TO UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET

 

(a) Reflects the sources and uses for the transactions as follows:

 

Sources

        

Interim revolver

   $ 25,500  

New debt securities

     185,000  
    


Total sources

   $ 210,500  
    


Uses

        

Repay existing debt

   $ 204,000  

Accrued interest on debt repaid

     1,218  

Estimated fees and expenses

     6,500  
    


Total uses

     211,718  
    


Net adjustment to cash

   $ (1,218 )
    


 

(b) Reflects the capitalization of estimated financing costs that we expect to incur in connection with the senior credit facilities and the new debt securities.

 

Capitalization of estimated financing costs

   $ 6,500  

Write-off of deferred financing costs related to debt being refinanced

     (6,569 )
    


     $ (69 )
    


 

9


UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE TWELVE MONTHS ENDED JUNE 30, 2005

 

     Historical

     Adjustments

    Pro Forma

 
            (in thousands)        

Income Statement Data:

                         

Net sales

   $ 408,689      $ —       $ 408,689  

Cost of goods sold

     217,783        (5,755 )(e)(g)     212,028  
    


  


 


Gross profit

     190,906        5,755       196,661  

Selling and administrative expenses

     168,641        343  (b)(c)(d)(g)     168,984  

Severance expenses

     17        —         17  

Merger expenses

     24,824        (23,625 )(f)     1,199  
    


  


 


Operating income (loss)

     (2,576 )      29,037       26,461  

Other income (expense), net

                         

Interest expense, net

     (13,721 )      (22,004 )(a)     (35,725 )

Loss on sale of facility and land

     (105 )      —         (105 )

Other, net

     530        —         530  
    


  


 


Other expense, net

     (13,296 )      (22,004 )     (35,300 )
    


  


 


Earnings (loss) before income taxes

     (15,872 )      7,033       (8,839 )

Income tax provision (benefit)

     (15,685 )      12,194  (h)     (3,491 )
    


  


 


Net loss

   $ (187 )    $ (5,161 )   $ (5,348 )
    


  


 


Cash Flows Data:

                         

Net cash provided by (used in):

                         

Operating activities

   $ (18,881 )    $ (6,593 )(i)   $ (25,474 )

Investing activities

     (385,102 )      —         (385,102 )

Financing activities

     408,140        —         408,140  

Capital expenditures

     7,864        —         7,864  

Depreciation and amortization

     19,573        2,172  (g)     21,745  

 

See accompanying notes to unaudited pro forma consolidated statements of operations.

 

10


UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2004

 

     Historical

     Adjustments

    Pro Forma

 
            (in thousands)        

Income Statement Data:

                         

Net sales

   $ 396,675      $ —       $ 396,675  

Cost of goods sold

     198,425        (172 )(g)     198,253  
    


  


 


Gross profit

     198,250        172       198,422  

Selling and administrative expenses

     166,732        734 (b)(c)(d)(g)     167,466  

Severance expenses

     20        —         20  

Merger expenses

     1,415        —         1,415  
    


  


 


Operating income (loss)

     30,083        (562 )     29,521  

Other income (expense), net

                         

Interest expense, net

     (3,584 )      (31,986 )(a)     (35,570 )

Loss on sale of building and land

     (146 )      —         (146 )

Other, net

     331        —         331  
    


  


 


Other expense, net

     (3,399 )      (31,986 )     (35,385 )
    


  


 


Earnings (loss) before income taxes

     26,684        (32,548 )     (5,864 )

Income tax provision (benefit)

     11,075        (13,391 )(h)     (2,316 )
    


  


 


Net earnings (loss)

   $ 15,609      $ (19,157 )   $ (3,548 )
    


  


 


Cash Flows Data:

                         

Net cash provided by (used in):

                         

Operating activities

   $ 7,209      $ (15,879 )(i)   $ (8,670 )

Investing activities

     (4,714 )      —         (4,714 )

Financing activities

     (812 )      —         (812 )

Capital expenditures

     9,525        —         9,525  

Depreciation and amortization

     17,472        3,912  (g)     21,384  

 

 

See accompanying notes to unaudited pro forma consolidated statements of operations.

 

11


UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE SIX MONTHS ENDED JUNE 30, 2004

 

     Historical

     Adjustments

    Pro Forma

 
            (in thousands)        

Income Statement Data:

                         

Net sales

   $ 186,013      $ —       $ 186,013  

Cost of goods sold

     93,585        (36 ) (g)     93,549  
    


  


 


Gross profit

     92,428        36       92,464  

Selling and administrative expenses

     82,729        388   (b)(c)(d)(g)     83,117  

Severance expenses

     3        —         3  

Merger expenses

     216        —         216  
    


  


 


Operating income (loss)

     9,480        (352 )     9,128  

Other income (expense), net

                         

Interest expense, net

     (1,859 )      (15,844 ) (a)     (17,703 )

Loss on sale of building and land

     (41 )      —         (41 )

Other, net

     (354 )      —         (354 )
    


  


 


Other expense, net

     (2,254 )      (15,844 )     (18,098 )
    


  


 


Earnings (loss) before income taxes

     7,226        (16,196 )     (8,970 )

Income tax provision (benefit)

     2,789        (6,332 ) (h)     (3,543 )
    


  


 


Net earnings (loss)

   $ 4,437      $ (9,864 )   $ (5,427 )
    


  


 


Cash Flows Data:

                         

Net cash provided by (used in):

                         

Operating activities

   $ (7,017 )    $ (8,193 ) (i)   $ (15,210 )

Investing activities

     (571 )            (571 )

Financing activities

     7,518              7,518  

Capital expenditures

     5,387              5,387  

Depreciation and amortization

     8,470        2,028   (g)     10,498  

 

See accompanying notes to unaudited pro forma consolidated statements of operations.

 

12


UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE SIX MONTHS ENDED JUNE 30, 2005

 

    Predecessor

     Successor

     Adjustments

   

Pro Forma

Combined


 
    Historical
Jan. 1, 2005
to Jan. 31,
2005


     Historical
Feb. 1, 2005
to June 30,
2005


      
    (in thousands)  

Income Statement Data:

                                 

Net sales

  $ 18,206      $ 179,821      $ —       $ 198,027  

Cost of goods sold

    9,718        103,225        (5,619 )(e)(g)     107,324  
   


  


  


 


Gross profit

    8,488        76,596        5,619       90,703  

Selling and administrative expenses

    11,475        73,163        (3 )(b)(c)(d)(g)     84,635  

Severance expenses

    —          —          —         —    

Merger expenses

    18,974        4,651        (23,625 )(f)     —    
   


  


  


 


Operating income (loss)

    (21,961 )      (1,218 )      29,247       6,068  

Other income (expense), net

                                 

Interest expense, net

    (264 )      (11,732 )      (5,862 )(a)     (17,858 )

Loss on sale of facility and land

    —          —          —         —    

Other, net

    (232 )      77        —         (155 )
   


  


  


 


Other expense, net

    (496 )      (11,655 )      (5,862 )     (18,013 )
   


  


  


 


Earnings (loss) before income taxes

    (22,457 )      (12,873 )      23,385       (11,945 )

Income tax provision (benefit)

    (24,434 )      463        19,253  (h)     (4,718 )
   


  


  


 


Net earnings (loss)

  $ 1,977      $ (13,336 )    $ 4,132     $ (7,227 )
   


  


  


 


Cash Flows Data:

                                 

Net cash provided by (used in):

                                 

Operating activities

  $ 190      $ (33,297 )    $ 1,093  (i)   $ (32,014 )

Investing activities

    (797 )      (380,162 )      —         (380,959 )

Financing activities

    (868 )      417,338        —         416,470  

Capital expenditures

    797        2,929        —         3,726  

Depreciation and amortization

    1,512        9,059        288  (g)     10,859  

 

See accompanying notes to unaudited pro forma consolidated statements of operations.

 

13


NOTES TO UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS

 

  (a) Represents pro forma interest expense resulting from our new capital structure, using, in the case of the interim revolver and the new debt securities, an assumed three-month LIBOR rate of 4.10% as follows:

 

    

Year Ended

December 31,

2004


   

Six Months Ended

June 30,


   

Twelve Months
Ended

June 30, 2005


 
       2004

    2005

   
     (in thousands)  

Cash interest expense:

                                

New debt facilities (1)

   $ 18,550     $ 9,196     $ 9,355     $ 18,709  

8% senior subordinated notes (2)

     14,000       7,000       7,000       14,000  

Existing debt (3)

     115       56       46       105  

Commitment fee (4)

     248       124       124       248  
    


 


 


 


Pro forma cash interest expense

     32,913       16,376       16,525       33,062  

Amortization of capitalized debt issuance costs (5)

     2,530       1,265       1,265       2,530  

Amortization of discount on senior subordinated notes

     127       62       68       133  
    


 


 


 


Pro forma interest expense

     35,570       17,703       17,858       35,725  

Less historical interest expense, net

     (3,584 )     (1,859 )     (11,996 )     (13,721 )
    


 


 


 


Total pro forma interest expense adjustment

   $ 31,986     $ 15,844     $ 5,862     $ 22,004  
    


 


 


 


 

  (1) Reflects pro forma cash interest expense on the interim revolver and the new debt securities.
  (2) Reflects pro forma cash interest expense on the principal balance of the senior subordinated notes at a fixed interest rate of 8.0%.
  (3) Reflects historical cash interest expense on other existing debt that is not being refinanced.
  (4) Reflects commitment fees of 0.50% on an assumed $49.5 million average undrawn balance under the interim revolver.
  (5) Reflects non-cash amortization of capitalized debt issuance costs. These costs are amortized over the term of the related debt.

 

A 1/8% change in interest rates would have the following effect on pro forma interest expense:

 

    

Year Ended

December 31,

2004


  

Six Months Ended

June 30,


  

Twelve Months
Ended

June 30, 2005


        2004

   2005

  
     (in thousands)

Interim revolver

   $       32    $        16    $         16    $         32

New debt securities

     219      110      110      219
    

  

  

  

Total

   $ 251    $ 126    $ 126    $ 251
    

  

  

  

 

  (b) Reflects the adjustment to selling and administrative expense for the annual monitoring fee due to Kelso after the close of the merger.
    

Year Ended

December 31,

2004


  

Six Months Ended

June 30,


  

Twelve Months
Ended

June 30, 2005


        2004

   2005

  
     (in thousands)

Sponsor financial advisory fee

   $   1,200    $      600    $         90    $       690
    

  

  

  

 

14


  (c) Reflects the pro forma adjustments to decreases in selling and administrative expenses for costs to be eliminated following consummation of the merger. The adjustments include a decrease in salary and related benefits as a result of the retirement of the former CEO, discontinuance of the employee stock option plan, and elimination of certain expenses that we no longer incur as a privately held company.

 

    

Year Ended

December 31,

2004


  

Six Months Ended

June 30,


  

Twelve Months
Ended

June 30, 2005


        2004

   2005

  
     (in thousands)

Reductions in selling and administrative expenses

   $ 3,583    $ 1,792    $ 316    $ 2,107
    

  

  

  

 

  (d) Adjustment to reflect decrease in selling and administrative expenses related to the elimination of the amortization of unrecognized prior service costs and transition obligations related to our pension plans.

 

    

Year Ended

December 31,

2004


  

Six Months Ended

June 30,


  

Twelve Months
Ended

June 30, 2005


        2004

   2005

  
     (in thousands)

Amortization of unrecognized prior service costs and transition obligations

   $ 967    $ 484    $ 105    $ 588
    

  

  

  

 

  (e) Reflects the elimination of the incremental cost of sales recorded in the period from February 1, 2005 to June 30, 2005 arising from the preliminary estimate of manufacturing profit added to inventory in purchase accounting.

 

    

Year Ended

December 31,

2004


  

Six Months Ended

June 30,


  

Twelve Months
Ended

June 30, 2005


        2004

   2005

  
     (in thousands)

Manufacturing profit included in cost of goods sold

   $ —      $ —      $ 5,579    $ 5,579
    

  

  

  

 

  (f) Reflects the elimination of merger expenses recorded from the period January 1, 2005 to June 30, 2005 primarily related to the change in control payments, legal and advisory fees and expenses incurred in connection with the merger.

 

    

Year Ended

December 31,

2004


  

Six Months Ended

June 30,


  

Twelve Months
Ended

June 30, 2005


        2004

   2005

  
     (in thousands)

Merger expenses

   $ —      $ —      $ 23,625    $ 23,625
    

  

  

  

 

  (g) Reflects the adjustment to depreciation and amortization expense for purchase accounting adjustments to property, plant and equipment and finite-lived identified intangible assets. The fair value of the finite-lived identified intangible assets (customer relationships) of approximately $105,000 is amortized on a straight-line basis over an estimated useful life of 20 years. The fair value of property and equipment is depreciated over the following estimated useful lives: buildings and improvements—8 to 16 years; machinery and equipment—3 to 15 years; furniture and fixtures—3 to 10 years; leasehold improvements—lesser of the useful life or the lease term.

 

15


    

Year Ended

December 31,

2004


   

Six Months Ended

June 30,


   

Twelve Months
Ended

June 30, 2005


 
       2004

    2005

   
     (in thousands)  

Decrease in depreciation and amortization included in cost of goods sold

   $ (172 )   $ (36 )   $ (40 )   $ (176 )

Increase in depreciation and amortization included in selling and administrative expenses

     4,084       2,064       328       2,348  
    


 


 


 


Total

   $ 3,912     $ 2,028     $ 288     $ 2,172  
    


 


 


 


 

  (h) Reflects the pro forma income tax provision (benefit) calculated at an assumed combined statutory rate of 39.5%.

 

  (i) Pro forma net cash provided by operating activities reflects the impact of the pro forma adjustments on income from continuing operations. Pro forma net cash provided by (used in) investing and financing activities and capital expenditures are assumed to be unchanged from the historic cash flows.

 

Disclosure Regarding Forward-Looking Statements

 

All statements other than statements of historical facts included in this report, including, without limitation, statements regarding our future financial results, efficiency improvements and expected future cost savings, are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Important factors that could cause actual results to differ materially from our expectations, or “cautionary statements,” include, without limitation:

 

    delays in introducing new products or failure of consumers to accept new products;

 

    actions by competitors which may result in mergers, technology improvement or new product introductions;

 

    our ability to realize cost savings and operational improvements;

 

    our dependence on certain national chain drug stores, food stores and mass merchandiser relationships due to the concentration of sales generated by such chains;

 

    changes in fashion-oriented color cosmetic trends;

 

    the effect on sales of lower retailer inventory targets;

 

    the effect on sales of political and/or economic conditions;

 

    our estimates of costs and benefits, cash flow from operations and capital expenditures;

 

    interest rate or foreign exchange rate changes affecting us;

 

    regulatory requirements and government regulatory action;

 

    failure to maintain satisfactory compliance with good manufacturing practice, or GMP, requirements;

 

    changes in product mix to products which are less profitable;

 

    shipment delays;

 

    depletion of inventory and increased production costs resulting from disruptions of operations at any of our manufacturing or distribution facilities;

 

    foreign currency fluctuations affecting our results of operations and the value of our foreign assets and liabilities;

 

    the relative prices at which we sell our products and our competitors sell their products in the same market;

 

    our operating and manufacturing costs outside of the United States;

 

    changes in the laws, regulations and policies, including changes in accounting standards, that affect, or will affect, us in the United States and/or abroad; and/or

 

    trends in the general economy.

 

We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

 

16


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DEL LABORATORIES, INC.
By:  

/s/ Joseph Sinicropi


Name:   Joseph Sinicropi
Title:   Executive Vice President and Chief Financial Officer

 

Date: October 17, 2005